DSIP vs Benzodiazepines Benzodiazepines modulate GABAergic activity to produce anxiolytic and sedative effects
Stacking BPC-157 with GLP-1 medications is a practical approach that combines tissue repair and gastroprotection with metabolic weight management
Within hours of administration, BDNF and its receptor TrkB increase in the hippocampus
Origin, Structure and Discovery BPC-157 was first isolated and characterised from human gastric juice in the early 1990s by researchers investigating naturally occurring protective compounds in the stomach lining
The general healing process can be divided into three overlapping phases: (1) inflammatory phase (days 15), (2) repair/proliferative phase (days 514) and (3) remodelling phase (days 1490+) (Hope and Saxby 2007)
Reported benefits (per available research): Studied for restoring more youthful pulsatile GH and IGF-1 secretion in older adults, based on a small 1997 randomized, placebo-controlled human trial of a closely related GHRH(1-29) analog published in the Journal of Clinical Endocrinology & Metabolism May support gains in lean body mass in men specifically: that same 16-week trial found a statistically significant increase in lean body mass in men but not in women, alongside a significant increase in skin thickness (a marker of dermal collagen) in both sexes Proposed to support broader recovery and body-composition goals tied to growth-hormone-axis activity, though sermorelin-specific modern adult trial data remains thin, and much of the anti-aging and muscle-building framing used in commercial marketing outpaces the current clinical evidence base Known risks and side effects: Injection-site reactions (pain, swelling, or redness) are the most commonly reported adverse event associated with sermorelin therapy in manufacturer drug-labeling data Headache, flushing, dizziness, difficulty swallowing, hyperactivity, drowsiness, and hives have also been reported less commonly per that same labeling data
